Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

<i>Summary</i>: Anti PD1/PD-L1 agents, including pembrolizumab, have revolutionized the oncological treatment of different types of cancer, including non-small cell lung cancer. The most frequent complications associated with this type of treatment are mild and are located at the thyroid...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Posado-Domínguez, María Escribano-Iglesias, Lorena Bellido-Hernández, Johana Gabriela León-Gil, María Asunción Gómez-Muñoz, Felipe Gómez-Caminero López, María Martín-Galache, Sandra M. Inés-Revuelta, Emilio Fonseca-Sánchez
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Oncology
Subjects:
sarcoid like reaction
lung cancer
panniculitis
immunotherapy
toxicity
Online Access:https://www.mdpi.com/1718-7729/31/11/540
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1718-7729/31/11/540

Similar Items